Literature DB >> 10701814

Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Public Health and Environmental Exposure to Cadmium Study Group.

J A Staessen1, T Kuznetsova, H A Roels, D Emelianov, R Fagard.   

Abstract

This prospective population study investigated in a random sample of 692 subjects (age 20-83 years) how changing environmental exposure to cadmium influenced blood pressure (BP) and the incidence of hypertension. At baseline (1985 to 1989; participation rate, 78%) and follow-up (1991 to 1995; re-examination rate, 81%), blood pressure was measured by conventional sphygmomanometry (CBP; 15 readings in total) and, at follow-up, also by 24-h ambulatory blood pressure monitoring (ABP). Systolic/diastolic CBP at baseline averaged 128.4/77.3 mm Hg. At baseline, blood cadmium concentration (B-Cd) and urinary cadmium excretion (U-Cd) averaged (geometric means) 11.1 nmol/L and 10.2 nmol/24 h. Over 5.2 years (median follow-up), B-Cd fell by 29.6% and U-Cd by 15.2%. B-Cd fell less in subjects living closer to three zinc smelters and in premenopausal women. During follow-up, systolic CBP decreased by 2.2 mm Hg in men and remained unchanged in women, and diastolic CBP increased by 1.8 mm Hg in both sexes. No relationship could be demonstrated between the secular trends in CBP and B-Cd or U-Cd or between B-Cd or U-Cd at baseline and the incidence of hypertension. In addition, in cross-sectional analyses involving the average of all available CBP measurements in each participant or 24-h ABP at follow-up (mean, 119.1/71.4 mm Hg), blood pressure was not correlated with B-Cd or U-Cd. In conclusion, environmental exposure to cadmium was not associated with higher CBP or 24-h ABP or with increased risk for hypertension. The lesser fall in B-Cd in the residents living closer to the zinc smelters or in premenopausal women underscores the necessity to sanitize cadmium-polluted areas and to systematically reinforce the preventive measures to be adopted by exposed communities to reduce cadmium uptake.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701814     DOI: 10.1016/s0895-7061(99)00187-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  24 in total

1.  Urinary cadmium concentration and the risk of ischemic stroke.

Authors:  Cheng Chen; Pengcheng Xun; Cari Tsinovoi; Leslie A McClure; John Brockman; Leslie MacDonald; Mary Cushman; Jianwen Cai; Lisa Kamendulis; Jason Mackey; Ka He
Journal:  Neurology       Date:  2018-06-22       Impact factor: 9.910

2.  Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.

Authors:  Nora Franceschini; Yu Deng; Michael F Flessner; John H Eckfeldt; Holly J Kramer; James P Lash; David J Lee; Michal L Melamed; Ashley E Moncrieft; Ana C Ricardo; Sylvia E Rosas; Robert C Kaplan; Leopoldo Raij; Jianwen Cai
Journal:  Nephrol Dial Transplant       Date:  2016-06-02       Impact factor: 5.992

Review 3.  Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies.

Authors:  Nora Franceschini; Daniel I Chasman; Rhonda M Cooper-DeHoff; Donna K Arnett
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 4.  Modern approaches to blood pressure measurement.

Authors:  J A Staessen; E T O'Brien; L Thijs; R H Fagard
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

Review 5.  The vascular system as a target of metal toxicity.

Authors:  Walter C Prozialeck; Joshua R Edwards; Daniel W Nebert; James M Woods; Aaron Barchowsky; William D Atchison
Journal:  Toxicol Sci       Date:  2007-10-18       Impact factor: 4.849

6.  Cadmium body burden, hypertension, and changes in blood pressure over time: results from a prospective cohort study in American Indians.

Authors:  Clare Oliver-Williams; Annie Green Howard; Ana Navas-Acien; Barbara V Howard; Maria Tellez-Plaza; Nora Franceschini
Journal:  J Am Soc Hypertens       Date:  2018-03-10

7.  Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001-2014.

Authors:  Nudrat Noor; Geng Zong; Ellen W Seely; Marc Weisskopf; Tamarra James-Todd
Journal:  Environ Int       Date:  2018-09-20       Impact factor: 9.621

Review 8.  Secondary hypertension: interfering substances.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

9.  Cadmium-induced hypertension is associated with renal myosin light chain phosphatase inhibition via increased T697 phosphorylation and p44 mitogen-activated protein kinase levels.

Authors:  Garsha McCalla; Paul D Brown; William C Cole; Christine Campbell; Chukwuemeka R Nwokocha
Journal:  Hypertens Res       Date:  2021-05-10       Impact factor: 3.872

10.  Cadmium levels in urine and mortality among U.S. adults.

Authors:  Andy Menke; Paul Muntner; Ellen K Silbergeld; Elizabeth A Platz; Eliseo Guallar
Journal:  Environ Health Perspect       Date:  2008-09-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.